These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2243511)

  • 21. [New discoveries on antidepressive treatment: serotonin is the key].
    Evenden J
    Lakartidningen; 1997 Sep; 94(38):3262-6. PubMed ID: 9379793
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopaminergic excitation in goat carotid body may be mediated by serotonin receptors.
    O'Halloran KD; Herman JK; Janssen PL; Bisgard GE
    Adv Exp Med Biol; 2000; 475():581-8. PubMed ID: 10849698
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonin receptors: subtypes, functional responses and therapeutic relevance.
    Saxena PR
    Pharmacol Ther; 1995 May; 66(2):339-68. PubMed ID: 7667401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal models in obsessive compulsive disorder.
    Olivier B
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():27-9. PubMed ID: 1517553
    [No Abstract]   [Full Text] [Related]  

  • 25. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study.
    Ashby CR; Minabe Y; Edwards E; Wang RY
    Brain Res; 1991 Jun; 550(2):181-91. PubMed ID: 1679370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5HT3-antagonist receptors: their role in drug-induced emesis.
    Dieras V; Extra JM; Le Bonniec M; Madelaine I; Espie M; Marty M
    Nouv Rev Fr Hematol (1978); 1990; 32(6):449-52. PubMed ID: 1983228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
    Gridelli C
    Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents.
    Peroutka SJ
    Pharmacol Rev; 1991 Dec; 43(4):579-86. PubMed ID: 1663621
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B; Naylor RJ
    Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serotonin-7 receptor as a novel therapeutic target.
    Stahl SM
    J Clin Psychiatry; 2010 Nov; 71(11):1414-5. PubMed ID: 21114946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between dopamine and 5-HT3 receptors suggest new treatments for psychosis and drug addiction.
    Tricklebank MD
    Trends Pharmacol Sci; 1989 Apr; 10(4):127-9. PubMed ID: 2665244
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.
    McCall RB; Clement ME
    Pharmacol Rev; 1994 Sep; 46(3):231-43. PubMed ID: 7831380
    [No Abstract]   [Full Text] [Related]  

  • 35. Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Eur J Pharmacol; 1997 May; 325(2-3):129-35. PubMed ID: 9163559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome.
    Humphrey PP; Bountra C; Clayton N; Kozlowski K
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():31-8. PubMed ID: 10429738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ; Tyers MB
    Pharmacol Ther; 1990; 47(2):181-202. PubMed ID: 2203069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects].
    Marco Igual M
    Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545
    [No Abstract]   [Full Text] [Related]  

  • 39. [Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations].
    Legeza VI
    Eksp Klin Farmakol; 1994; 57(4):72-5. PubMed ID: 7950795
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.
    Parikh PM; Shah SR; Shah SC; Sheth V; Patel RA; Shah KC; Jain PK
    Indian J Cancer; 1996 Mar; 33(1):17-20. PubMed ID: 9063013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.